Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Distinct Structures and Dynamics of Chromatosomes with Different Human Linker Histone Isoforms
  2. Zhou, Bing-Rui; Feng, Hanqiao; Kale, Seyit; Fox,Tara; Khant,Htet; De Val Alda,Natalia; Ghirlando, Rodolfo; Panchenko, Anna R; Bai, Yawen
  3. Molecular cell. 2021, Jan 7; 81(1): 166-182.
  1. 2.   Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes
  2. Zhou, Tongqing; Teng, I-Ting; Olia, Adam S; Cerutti, Gabriele; Gorman, Jason; Nazzari, Alexandra; Shi, Wei; Tsybovsky,Yaroslav; Wang, Lingshu; Wang, Shuishu; Zhang, Baoshan; Zhang, Yi; Katsamba, Phinikoula S; Petrova, Yuliya; Banach, Bailey B; Fahad, Ahmed S; Liu, Lihong; Lopez Acevedo, Sheila N; Madan, Bharat; Oliveira de Souza, Matheus; Pan, Xiaoli; Wang, Pengfei; Wolfe, Jacy R; Yin, Michael; Ho, David D; Phung, Emily; DiPiazza, Anthony; Chang, Lauren A; Abiona, Olubukola M; Corbett, Kizzmekia S; DeKosky, Brandon J; Graham, Barney S; Mascola, John R; Misasi, John; Ruckwardt, Tracy; Sullivan, Nancy J; Shapiro, Lawrence; Kwong, Peter D
  3. Cell reports. 2020, Oct 27; 33(4): 108322.
  1. 3.   Efficient killing of CD22(+) tumor cells by a humanized diabody-RNase fusion protein
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Seeber, S.; Rybak, S. M.
  3. Biochemical and Biophysical Research Communications. 2005, JUN 3; 331(2): 595-602.
  1. 4.   Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. British Journal of Haematology. 2005, MAR; 128(5): 602-609.
  1. 5.   Favorable scaffolds: proteins with different sequence, structure and function may associate in similar ways
  2. Keskin, O.; Nussinov, R.
  3. Protein Engineering Design & Selection. 2005, JAN; 18(1): 11-24.
  1. 6.   A dimeric angiogenin immunofusion protein mediates selective toxicity towards CD22(+) tumor cells
  2. Arndt, M. A. E.; Krauss, J.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. Journal of Immunotherapy. 2005, MAY-JUN; 28(3): 245-251.
  1. 7.   Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification
  2. Nellis, D. F.; Ekstrom, D. L.; Kirpotin, D. B.; Zhu, J. W.; Andersson, R.; Broadt, T. L.; Ouellette, T. F.; Perkins, S. C.; Roach, J. M.; Drummond, D. C.; Hong, K. L.; Marks, J. D.; Park, J. W.; Giardina, S. L.
  3. Biotechnology Progress. 2005, JAN-FEB; 21(1): 205-220.
  1. 8.   Antigen binding and stability properties of non-covalently linked anti-CD22 single-chain Fv dimers
  2. Arndt, M. A. E.; Krauss, R.; Rybak, S. M.
  3. Febs Letters. 2004, DEC 17; 578(3): 257-261.
  1. 9.   Fermentation process development of F5 anti-Erb B2 single chain antibody expressed in E. coli
  2. Zhu, J. W.; Testerman, R.; Luo, J.; Ekstrom, D.; Spenser, G.; Miller, D.; Ward, L.; Reeb, S.; Jiang, H.; Burnette, A.; Mitra, G.
  3. Abstracts of Papers of the American Chemical Society. 2004, MAR 28; 227(073-BIOT, Part 1): U134-U134.
  1. 10.   The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation
  2. Angeloni, D.; Danilkovitch-Miagkova, A.; Miagkov, A.; Leonard, E. J.; Lerman, M. I.
  3. Journal of Biological Chemistry. 2004 279(5): 3726-3732.
  1. 11.   Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli
  2. Feher, A.; Boross, P.; Sperka, T.; Oroszlan, S.; Tozser, J.
  3. Protein Expression and Purification. 2004 35(1): 62-68.
  1. 12.   Impact of antibody framework residue V-H-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Zhu, Z.; Newton, D. L.; Vu, B. K.; Choudhry, V.; Darbha, R.; Ji, X.; Courtenay-Luck, N. S.; Deonarain, M. P.; Richards, J.; Rybak, S. M.
  3. British Journal of Cancer. 2004 90(9): 1863-1870.
  1. 13.   Improved breadth and potency of an HIV-1-neutralizing human single-chain antibody by random mutagenesis and sequential antigen panning
  2. Zhang, M. Y.; Shu, Y. U.; Rudolph, D.; Prabakaran, P.; Labrijn, A. F.; Zwick, M. B.; Lal, R. B.; Dimitrov, D. S.
  3. Journal of Molecular Biology. 2004 335(1): 209-219.
  1. 14.   Specificity grafting of human antibody frameworks selected from a phage display library: generation of a highly stable humanized anti-CD22 single-chain Fv fragment
  2. Krauss, J.; Arndt, M. A. E.; Martin, A. C. R.; Liu, H. T.; Rybak, S. M.
  3. Protein Engineering. 2003 16(10): 753-759.
  1. 15.   Recombinant antibodies for the diagnosis and treatment of cancer
  2. Krauss, J.
  3. Molecular Biotechnology. 2003 25(1): 1-17.
  1. 16.   Diverting a protein from its cellular location by intracellular antibodies - The case of p21Ras
  2. Lener, M.; Horn, I. R.; Cardinale, A.; Messina, S.; Nielsen, U. B.; Rybak, S. M.; Hoogenboom, H. R.; Cattaneo, A.; Biocca, S.
  3. European Journal of Biochemistry. 2000 267(4): 1196-1205.
  1. 17.   Single-chain variable fragments selected on the 57-76 p21Ras neutralising epitope from phage antibody libraries recognise the parental protein
  2. Persic, L.; Horn, I. R.; Rybak, S.; Cattaneo, A.; Hoogenboom, H. R.; Bradbury, A.
  3. Febs Letters. 1999 443(2): 112-116.
  1. 18.   A Recombinant Single-Chain Human Class Ii Mhc Molecule (Hla-Dr1) As a Covalently Linked Heterotrimer of a Chain, Beta Chain, and Antigenic Peptide, With Immunogenicity in Vitro and Reduced Affinity For Bacterial Superantigens
  2. Zhu, X. J.; Bavari, S.; Ulrich, R.; Sadeghnasseri, S.; Ferrone, S.; McHugh, L.; Mage, M.
  3. European Journal of Immunology. 1997 27(8): 1933-1941.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel